ПРЕДИКТОРЫ ПРОГНОЗА ПЕРИПАРТАЛЬНОЙ КАРДИОМИОПАТИИ: СОВРЕМЕННОЕ СОСТОЯНИЕ ПРОБЛЕМЫ
Обзорная статья
Дата публикации: сентября 21, 2020
Ключевые слова
сердечная недостаточность
перипартальная кардиомиопатия
беременность
перипартальная кардиомиопатия
беременность
Как цитировать
Иосава И. К., Суворова Н. Н., Савина Н. М. ПРЕДИКТОРЫ ПРОГНОЗА ПЕРИПАРТАЛЬНОЙ КАРДИОМИОПАТИИ: СОВРЕМЕННОЕ СОСТОЯНИЕ ПРОБЛЕМЫ // КРЕМЛЕВСКАЯ МЕДИЦИНА<br><i>клинический вестник</i>. 2020. Т. № 3. С. 87-97.
Аннотация
В обзоре обсуждаются определение перипартальной кардиомиопатии (ПКМП), распространенность заболевания в разных странах и регионах, современные патогенетические механизмы ПКМП. Описываются независимые предикторы неблагоприятного исхода ПКМП, роль артериальной гипертензии / преэклампии в развитии заболевания, генетические аспекты и биомаркеры ПКМП. Также выделяются факторы риска, полученные в последних регистровых и перспективных исследованиях ПКМП.Литература
1. Sliwa K. et al. Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM) EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM // European journal of heart failure. – 2017. – V. 19. – №. 9. – P. 1131-1141.
2. Bauersachs J. et al. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy // European journal of heart failure. – 2019. – V. 21. – №. 7. – P. 827-843.
3. Cruz M. O., Briller J., Hibbard J. U. New insights in peripartum cardiomyopathy // Obstet Gynecol Clin N Am. – 2018. – V. 45. – P. 281-298.
4. Modi K. A. et al. Poor outcome of indigent patients with peripartum cardiomyopathy in the United States // American journal of obstetrics and gynecology. – 2009. – V. 201. – №. 2. – P. 171. e1-171. e5
5. Sliwa K. et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy // European journal of heart failure. – 2010. – V. 12. – №. 8. – P. 767-778. doi: 10.1093/eurjhf/hfq120
6. Elkayam U. et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation // Circulation. – 2005. – V. 111. – №. 16. – P. 2050-2055.
7. Citro R. et al. Takotsubo syndrome after cesarean section: rare but possible // Journal of the American College of Cardiology. – 2018. – V. 71. – №. 16. – P. 1838-1839. doi: 10.1016/j.jacc.2018.02.035
8. Karaye K. M. et al. Incidence, clinical characteristics, and risk factors of peripartum cardiomyopathy in Nigeria: results from the PEACE Registry // ESC heart failure. – 2020. – V. 7. – №. 1. – P. 236-244. doi: 10.1002/ehf2.12562
9. Isogai T., Kamiya C. A. Worldwide incidence of peripartum cardiomyopathy and overall maternal mortality // International heart journal. – 2019. – V. 60. – №. 3. – P. 503-511.
10. Kezerle L. et al. A Population-based Study of Peripartum Cardiomyopathy in Southern Israel: Are Bedouin Women a New High-risk Group? // Rambam Maimonides medical journal. – 2018. – V. 9. – №. 2.
11. Lee S. et al. Incidence, risk factors, and clinical characteristics of peripartum cardiomyopathy in South Korea // Circulation: Heart Failure. – 2018. – V. 11. – №. 4. – P. e004134
12. Arany Z. Understanding peripartum cardiomyopathy // Annual review of medicine. – 2018. – V. 69. – P. 165-176.
13. Honigberg M. C., Givertz M. M. Peripartum cardiomyopathy // Bmj. – 2019. – V. 364. – P. k5287
14. Hilfiker-Kleiner D., Sliwa K. Pathophysiology and epidemiology of peripartum cardiomyopathy // Nature reviews cardiology. – 2014. – V. 11. – №. 6. – P. 364-370
15. Haghikia A. et al. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy // Basic research in cardiology. – 2013. – V. 108. – №. 4. – P. 366. doi: 10.1007/s00395-013-0366-9
16. Курбанов Р. Д. и др. Влияние бромокриптина на клинические и лабораторные показатели у больных с перипартальной кардиомиопатией // Кардиология. – 2020. – Т. 60. – №. 6. – С. 58–62. [Kurbanov R. D. et al. The Effect of Bromocriptine on Clinical and Laboratory Parameters in Patients With Peripartum Cardiomyopathy. Kardiologiia. – 2020 – V. 60. – №. 6. – P. 58–62. In Russian]. doi: 10.18087/cardio.2020.6.n984.
17. Mebazaa A. et al. Imbalanced angiogenesis in peripartum cardiomyopathy―diagnostic value of placenta growth factor // Circulation Journal. – 2017. – P. CJ-16-1193
18. Patten I. S. et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy // Nature. – 2012. – V. 485. – №. 7398. – P. 333-338
19. Kolte D. et al. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population‐based study // Journal of the American Heart Association. – 2014. – V. 3. – №. 3. – P. e001056
20. Gentry M. et al. “African-American women have a higher risk for developing peripartum cardiomyopathy.” Journal of the American College of Cardiology 55 7 (2010): 654-659.
21. Karaye K. M., Habib A. G., Sliwa K. Epidemiology of Peripartum Cardiomyopathy in Africa // International Cardiovascular Forum Journal. – 2018. – V. 15. – P. 6-11.
22. Gouveia M. H. et al. Origins, Admixture Dynamics, and Homogenization of the African Gene Pool in the Americas // Molecular Biology and Evolution. – 2020. – V. 37. – №. 6. – P. 1647-1656
23. Fett J.D., Sundstrom J.B., Etta King M. et al. Mother–daughter peripartum cardiomyopathy // International journal of cardiology. – 2002. – V. 86. – №. 2. – P. 331-332.
24. Baruteau A. E. et al. Can peripartum cardiomyopathy be familial? // International journal of cardiology. – 2009. – V. 137. – №. 2. – P. 183-185
25. Morales A. et al. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy // Circulation. – 2010. – V. 121. – №. 20. – P. 2176-2182. doi: 10.1161/CIRCULATIONAHA.109.931220
26. Kamiya C. A. et al. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders // Circulation Journal. – 2011. – P. 1105251244-1105251244.
27. Bello N., Rendon I. S. H., Arany Z. The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis // Journal of the American College of Cardiology. – 2013. – V. 62. – №. 18. – P. 1715-1723 doi: 10.1016/j.jacc.2013.08.717
28. Behrens I. et al. Hypertensive disorders of pregnancy and peripartum cardiomyopathy: a nationwide cohort study // PloS one. – 2019. – V. 14. – №. 2. - P. e0211857-e0211857.
29. Parikh P., Blauwet L. Peripartum Cardiomyopathy and Preeclampsia: Overlapping Diseases of Pregnancy // Current Hypertension Reports. – 2018. – V. 20. – №. 8. – P. 1-8
30. Malhamé I. et al. Peripartum cardiomyopathy with co-incident preeclampsia: A cohort study of clinical risk factors and outcomes among commercially insured women // Pregnancy hypertension. – 2019. – V. 17. – P. 82-88
31. Goland S. et al. Differences in clinical profile of African-American women with peripartum cardiomyopathy in the United States // Journal of cardiac failure. – 2013. – V. 19. – №. 4. – P. 214-218
32. Irizarry O. C. et al. Comparison of Clinical Characteristics and Outcomes of Peripartum Cardiomyopathy Between African American and Non–African American Women // JAMA cardiology. – 2017. – V. 2. – №. 11. – P. 1256-1260
33. Shani, Hagit, et al. "Peripartum cardiomyopathy–risk factors, characteristics and long-term follow-up." Journal of Perinatal Medicine 43.1 (2015): 95-101. doi: 10.1515/jpm-2014-0086
34. Li W., Li H., Long Y. Clinical characteristics and long-term predictors of persistent left ventricular systolic dysfunction in peripartum cardiomyopathy // Canadian Journal of Cardiology. – 2016. – V. 32. – №. 3. – P. 362-368.
35. Cooper L. T. et al. Myocardial recovery in peripartum cardiomyopathy: prospective comparison with recent onset cardiomyopathy in men and nonperipartum women // Journal of cardiac failure. – 2012. – V. 18. – №. 1. – P. 28-33.)
36. McNamara D. M. et al. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy) // Journal of the American College of Cardiology. – 2015. – V. 66. – №. 8. – P. 905-914.
37. Blauwet L. A. et al. Predictors of outcome in 176 South African patients with peripartum cardiomyopathy // Heart. – 2013. – V. 99. – №. 5. – P. 308-313.
38. Karaye K. M., Lindmark K., Henein M. Y. One year survival in Nigerians with peripartum cardiomyopathy // Heart views: the official journal of the Gulf Heart Association. – 2016. – V. 17. – №. 2. – P. 55.
39. Duran N. et al. Predictors of prognosis in patients with peripartum cardiomyopathy // International Journal of Gynecology & Obstetrics. – 2008. – V. 101. – №. 2. – P. 137-140. doi:10.1016/j.ijgo.2007.11.007
40. Loyaga-Rendon R. Y. et al. Outcomes of patients with peripartum cardiomyopathy who received mechanical circulatory support: data from the interagency registry for mechanically assisted circulatory support // Circulation: Heart Failure. – 2014. – V. 7. – №. 2. – P. 300-309.
41. Goland S. et al. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy // Journal of cardiac failure. – 2011. – V. 17. – №. 5. – P. 426-430.
42. Amos A. M., Jaber W. A., Russell S. D. Improved outcomes in peripartum cardiomyopathy with contemporary // American heart journal. – 2006. – V. 152. – №. 3. – P. 509-513. doi: 10.1016/j.ahj.2006.02.008
43. Blauwet L. A. et al. Right ventricular function in peripartum cardiomyopathy at presentation is associated with subsequent left ventricular recovery and clinical outcomes // Circulation: Heart Failure. – 2016. – V. 9. – №. 5. – P. e002756.
44. Haghikia A,et al. Prognostic implication of right ventricular involvement in peripartum cardiomyopathy: a cardiovascular magnetic resonance study. ESC Heart Fail. 2015; 2:139–149
45. Sugahara M. et al. Global Left Ventricular Strain at Presentation Is Associated with Subsequent Recovery in Patients with Peripartum Cardiomyopathy // Journal of the American Society of Echocardiography. – 2019. – V. 32. – №. 12. – P. 1565-1573
46. Дорошенко Д. А. и др. Диагностические аспекты спекл-трекинг-эхокардиографии у беременных с синдромом дилатационной кардиомиопатии // Медицинский совет. – 2016. – №. 5. – С. 128-130 [Doroshenko D.A et al. Diagnostic aspects of speckle tracking echocardiography in pregnant women with dilated cardiomyopathy syndrome // Medical Council. - 2016. - № 5. - P. 128-130. In Russian].
47. Schelbert E. B. et al. Myocardial damage detected by late gadolinium enhancement cardiac magnetic resonance is uncommon in peripartum cardiomyopathy // Journal of the American Heart Association. – 2017. – V. 6. – №. 4. – P. e005472. doi: 10.1161/JAHA.117.005472
48. Liang Y. D. et al. Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping // Journal of Cardiovascular Magnetic Resonance. – 2020. – V. 22. – №. 1. – P. 2. doi: 10.1186/s12968-019-0590-z
49. Hoevelmann J. et al. Detection and management of arrhythmias in peripartum cardiomyopathy // Cardiovascular Diagnosis and Therapy. – 2020. – V. 10. – №. 2. – P. 325
50. Mbakwem A. C. et al. 2371 Electrocardiographic features and their echocardiographic correlates in peripartum cardiomyopathy based on the EURObservational registry on PPCM // European Heart Journal. – 2019. – V. 40. – №. Supplement_1. – P. ehz748. 0138
51. Tekin Tak B. et al. Fragmented QRS as a candidate marker for left ventricular nonrecovery in patients with peripartum cardiomyopathy // Annals of Noninvasive Electrocardiology. – 2020. – V. 25. – №. 3. – P. e12708. doi: 10.1111/anec.12708
52. Libhaber E. et al. Low systolic blood pressure and high resting heart rate as predictors of outcome in patients with peripartum cardiomyopathy // International journal of cardiology. – 2015. – V. 190. – P. 376-382. doi:10.1016/j.ijcard.2015.04.081
53. Bauersachs J. et al. Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy // European journal of heart failure. – 2016. – V. 18. – №. 9. – P. 1096-1105
54. Haghikia A. et al. Early ivabradine treatment in patients with acute peripartum cardiomyopathy: subanalysis of the German PPCM registry // International journal of Cardiology. – 2016. – V. 216. – P. 165-167.).
55. Wu V. C. C. et al. Clinical outcomes of peripartum cardiomyopathy: a 15-year nationwide population-based study in Asia // Medicine. – 2017. – V. 96. – №. 43. – P. e8374.
56. Ersbøll A. S. et al. Peripartum cardiomyopathy in Denmark: a retrospective, population‐based study of incidence, management and outcome // European Journal of Heart Failure. – 2017. – V. 19. – №. 12. – P. 1712-1720.
57. Barasa A. et al. Symptomatic recovery and pharmacological management in a clinical cohort with peripartum cardiomyopathy // The Journal of Maternal-Fetal & Neonatal Medicine. – 2018. – V. 31. – №. 10. – P. 1342-1349
58. Lindley K. J., Verma A. K., Blauwet L. A. Peripartum cardiomyopathy: progress in understanding the etiology, management, and prognosis // Heart failure clinics. – 2019. – V. 15. – №. 1. – P. 29-39.doi: 10.1016/j.hfc.2018.08.004.
59. Dennis AT, Castro J, Carr C, Simmons S, Permezel M, Royse C. Haemodynamics in women with untreated pre-eclampsia. Anaesthesia 2012;67:1105–18.
60. Ntusi N. B. A. et al. Pregnancy-associated heart failure: a comparison of clinical presentation and outcome between hypertensive heart failure of pregnancy and idiopathic peripartum cardiomyopathy // PloS one. – 2015. – V. 10. – №. 8. – P. e0133466. doi: 10.1371/journal.pone.0133466
61. Van Spaendonck-Zwarts K. Y. et al. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy // Circulation. – 2010. – V. 121. – №. 20. – P. 2169-2175
62. Van Spaendonck-Zwarts K. Y. et al. Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy // European heart journal. – 2014. – V. 35. – №. 32. – P. 2165-2173
63. Ware J. S. et al. Shared genetic predisposition in peripartum and dilated cardiomyopathies // New England Journal of Medicine. – 2016. – V. 374. – №. 3. – С. 233-241.]
64. Sliwa K. et al. Long‐term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy // European journal of heart failure. – 2018. – V. 20. – №. 6. – P. 951-962. doi:10.1002/ejhf.1178
65. Azibani F., Sliwa K. Peripartum cardiomyopathy: an update // Current Heart Failure Reports. – 2018. – V. 15. – №. 5. – P. 297-306.
2. Bauersachs J. et al. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy // European journal of heart failure. – 2019. – V. 21. – №. 7. – P. 827-843.
3. Cruz M. O., Briller J., Hibbard J. U. New insights in peripartum cardiomyopathy // Obstet Gynecol Clin N Am. – 2018. – V. 45. – P. 281-298.
4. Modi K. A. et al. Poor outcome of indigent patients with peripartum cardiomyopathy in the United States // American journal of obstetrics and gynecology. – 2009. – V. 201. – №. 2. – P. 171. e1-171. e5
5. Sliwa K. et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy // European journal of heart failure. – 2010. – V. 12. – №. 8. – P. 767-778. doi: 10.1093/eurjhf/hfq120
6. Elkayam U. et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation // Circulation. – 2005. – V. 111. – №. 16. – P. 2050-2055.
7. Citro R. et al. Takotsubo syndrome after cesarean section: rare but possible // Journal of the American College of Cardiology. – 2018. – V. 71. – №. 16. – P. 1838-1839. doi: 10.1016/j.jacc.2018.02.035
8. Karaye K. M. et al. Incidence, clinical characteristics, and risk factors of peripartum cardiomyopathy in Nigeria: results from the PEACE Registry // ESC heart failure. – 2020. – V. 7. – №. 1. – P. 236-244. doi: 10.1002/ehf2.12562
9. Isogai T., Kamiya C. A. Worldwide incidence of peripartum cardiomyopathy and overall maternal mortality // International heart journal. – 2019. – V. 60. – №. 3. – P. 503-511.
10. Kezerle L. et al. A Population-based Study of Peripartum Cardiomyopathy in Southern Israel: Are Bedouin Women a New High-risk Group? // Rambam Maimonides medical journal. – 2018. – V. 9. – №. 2.
11. Lee S. et al. Incidence, risk factors, and clinical characteristics of peripartum cardiomyopathy in South Korea // Circulation: Heart Failure. – 2018. – V. 11. – №. 4. – P. e004134
12. Arany Z. Understanding peripartum cardiomyopathy // Annual review of medicine. – 2018. – V. 69. – P. 165-176.
13. Honigberg M. C., Givertz M. M. Peripartum cardiomyopathy // Bmj. – 2019. – V. 364. – P. k5287
14. Hilfiker-Kleiner D., Sliwa K. Pathophysiology and epidemiology of peripartum cardiomyopathy // Nature reviews cardiology. – 2014. – V. 11. – №. 6. – P. 364-370
15. Haghikia A. et al. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy // Basic research in cardiology. – 2013. – V. 108. – №. 4. – P. 366. doi: 10.1007/s00395-013-0366-9
16. Курбанов Р. Д. и др. Влияние бромокриптина на клинические и лабораторные показатели у больных с перипартальной кардиомиопатией // Кардиология. – 2020. – Т. 60. – №. 6. – С. 58–62. [Kurbanov R. D. et al. The Effect of Bromocriptine on Clinical and Laboratory Parameters in Patients With Peripartum Cardiomyopathy. Kardiologiia. – 2020 – V. 60. – №. 6. – P. 58–62. In Russian]. doi: 10.18087/cardio.2020.6.n984.
17. Mebazaa A. et al. Imbalanced angiogenesis in peripartum cardiomyopathy―diagnostic value of placenta growth factor // Circulation Journal. – 2017. – P. CJ-16-1193
18. Patten I. S. et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy // Nature. – 2012. – V. 485. – №. 7398. – P. 333-338
19. Kolte D. et al. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population‐based study // Journal of the American Heart Association. – 2014. – V. 3. – №. 3. – P. e001056
20. Gentry M. et al. “African-American women have a higher risk for developing peripartum cardiomyopathy.” Journal of the American College of Cardiology 55 7 (2010): 654-659.
21. Karaye K. M., Habib A. G., Sliwa K. Epidemiology of Peripartum Cardiomyopathy in Africa // International Cardiovascular Forum Journal. – 2018. – V. 15. – P. 6-11.
22. Gouveia M. H. et al. Origins, Admixture Dynamics, and Homogenization of the African Gene Pool in the Americas // Molecular Biology and Evolution. – 2020. – V. 37. – №. 6. – P. 1647-1656
23. Fett J.D., Sundstrom J.B., Etta King M. et al. Mother–daughter peripartum cardiomyopathy // International journal of cardiology. – 2002. – V. 86. – №. 2. – P. 331-332.
24. Baruteau A. E. et al. Can peripartum cardiomyopathy be familial? // International journal of cardiology. – 2009. – V. 137. – №. 2. – P. 183-185
25. Morales A. et al. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy // Circulation. – 2010. – V. 121. – №. 20. – P. 2176-2182. doi: 10.1161/CIRCULATIONAHA.109.931220
26. Kamiya C. A. et al. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders // Circulation Journal. – 2011. – P. 1105251244-1105251244.
27. Bello N., Rendon I. S. H., Arany Z. The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis // Journal of the American College of Cardiology. – 2013. – V. 62. – №. 18. – P. 1715-1723 doi: 10.1016/j.jacc.2013.08.717
28. Behrens I. et al. Hypertensive disorders of pregnancy and peripartum cardiomyopathy: a nationwide cohort study // PloS one. – 2019. – V. 14. – №. 2. - P. e0211857-e0211857.
29. Parikh P., Blauwet L. Peripartum Cardiomyopathy and Preeclampsia: Overlapping Diseases of Pregnancy // Current Hypertension Reports. – 2018. – V. 20. – №. 8. – P. 1-8
30. Malhamé I. et al. Peripartum cardiomyopathy with co-incident preeclampsia: A cohort study of clinical risk factors and outcomes among commercially insured women // Pregnancy hypertension. – 2019. – V. 17. – P. 82-88
31. Goland S. et al. Differences in clinical profile of African-American women with peripartum cardiomyopathy in the United States // Journal of cardiac failure. – 2013. – V. 19. – №. 4. – P. 214-218
32. Irizarry O. C. et al. Comparison of Clinical Characteristics and Outcomes of Peripartum Cardiomyopathy Between African American and Non–African American Women // JAMA cardiology. – 2017. – V. 2. – №. 11. – P. 1256-1260
33. Shani, Hagit, et al. "Peripartum cardiomyopathy–risk factors, characteristics and long-term follow-up." Journal of Perinatal Medicine 43.1 (2015): 95-101. doi: 10.1515/jpm-2014-0086
34. Li W., Li H., Long Y. Clinical characteristics and long-term predictors of persistent left ventricular systolic dysfunction in peripartum cardiomyopathy // Canadian Journal of Cardiology. – 2016. – V. 32. – №. 3. – P. 362-368.
35. Cooper L. T. et al. Myocardial recovery in peripartum cardiomyopathy: prospective comparison with recent onset cardiomyopathy in men and nonperipartum women // Journal of cardiac failure. – 2012. – V. 18. – №. 1. – P. 28-33.)
36. McNamara D. M. et al. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy) // Journal of the American College of Cardiology. – 2015. – V. 66. – №. 8. – P. 905-914.
37. Blauwet L. A. et al. Predictors of outcome in 176 South African patients with peripartum cardiomyopathy // Heart. – 2013. – V. 99. – №. 5. – P. 308-313.
38. Karaye K. M., Lindmark K., Henein M. Y. One year survival in Nigerians with peripartum cardiomyopathy // Heart views: the official journal of the Gulf Heart Association. – 2016. – V. 17. – №. 2. – P. 55.
39. Duran N. et al. Predictors of prognosis in patients with peripartum cardiomyopathy // International Journal of Gynecology & Obstetrics. – 2008. – V. 101. – №. 2. – P. 137-140. doi:10.1016/j.ijgo.2007.11.007
40. Loyaga-Rendon R. Y. et al. Outcomes of patients with peripartum cardiomyopathy who received mechanical circulatory support: data from the interagency registry for mechanically assisted circulatory support // Circulation: Heart Failure. – 2014. – V. 7. – №. 2. – P. 300-309.
41. Goland S. et al. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy // Journal of cardiac failure. – 2011. – V. 17. – №. 5. – P. 426-430.
42. Amos A. M., Jaber W. A., Russell S. D. Improved outcomes in peripartum cardiomyopathy with contemporary // American heart journal. – 2006. – V. 152. – №. 3. – P. 509-513. doi: 10.1016/j.ahj.2006.02.008
43. Blauwet L. A. et al. Right ventricular function in peripartum cardiomyopathy at presentation is associated with subsequent left ventricular recovery and clinical outcomes // Circulation: Heart Failure. – 2016. – V. 9. – №. 5. – P. e002756.
44. Haghikia A,et al. Prognostic implication of right ventricular involvement in peripartum cardiomyopathy: a cardiovascular magnetic resonance study. ESC Heart Fail. 2015; 2:139–149
45. Sugahara M. et al. Global Left Ventricular Strain at Presentation Is Associated with Subsequent Recovery in Patients with Peripartum Cardiomyopathy // Journal of the American Society of Echocardiography. – 2019. – V. 32. – №. 12. – P. 1565-1573
46. Дорошенко Д. А. и др. Диагностические аспекты спекл-трекинг-эхокардиографии у беременных с синдромом дилатационной кардиомиопатии // Медицинский совет. – 2016. – №. 5. – С. 128-130 [Doroshenko D.A et al. Diagnostic aspects of speckle tracking echocardiography in pregnant women with dilated cardiomyopathy syndrome // Medical Council. - 2016. - № 5. - P. 128-130. In Russian].
47. Schelbert E. B. et al. Myocardial damage detected by late gadolinium enhancement cardiac magnetic resonance is uncommon in peripartum cardiomyopathy // Journal of the American Heart Association. – 2017. – V. 6. – №. 4. – P. e005472. doi: 10.1161/JAHA.117.005472
48. Liang Y. D. et al. Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping // Journal of Cardiovascular Magnetic Resonance. – 2020. – V. 22. – №. 1. – P. 2. doi: 10.1186/s12968-019-0590-z
49. Hoevelmann J. et al. Detection and management of arrhythmias in peripartum cardiomyopathy // Cardiovascular Diagnosis and Therapy. – 2020. – V. 10. – №. 2. – P. 325
50. Mbakwem A. C. et al. 2371 Electrocardiographic features and their echocardiographic correlates in peripartum cardiomyopathy based on the EURObservational registry on PPCM // European Heart Journal. – 2019. – V. 40. – №. Supplement_1. – P. ehz748. 0138
51. Tekin Tak B. et al. Fragmented QRS as a candidate marker for left ventricular nonrecovery in patients with peripartum cardiomyopathy // Annals of Noninvasive Electrocardiology. – 2020. – V. 25. – №. 3. – P. e12708. doi: 10.1111/anec.12708
52. Libhaber E. et al. Low systolic blood pressure and high resting heart rate as predictors of outcome in patients with peripartum cardiomyopathy // International journal of cardiology. – 2015. – V. 190. – P. 376-382. doi:10.1016/j.ijcard.2015.04.081
53. Bauersachs J. et al. Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy // European journal of heart failure. – 2016. – V. 18. – №. 9. – P. 1096-1105
54. Haghikia A. et al. Early ivabradine treatment in patients with acute peripartum cardiomyopathy: subanalysis of the German PPCM registry // International journal of Cardiology. – 2016. – V. 216. – P. 165-167.).
55. Wu V. C. C. et al. Clinical outcomes of peripartum cardiomyopathy: a 15-year nationwide population-based study in Asia // Medicine. – 2017. – V. 96. – №. 43. – P. e8374.
56. Ersbøll A. S. et al. Peripartum cardiomyopathy in Denmark: a retrospective, population‐based study of incidence, management and outcome // European Journal of Heart Failure. – 2017. – V. 19. – №. 12. – P. 1712-1720.
57. Barasa A. et al. Symptomatic recovery and pharmacological management in a clinical cohort with peripartum cardiomyopathy // The Journal of Maternal-Fetal & Neonatal Medicine. – 2018. – V. 31. – №. 10. – P. 1342-1349
58. Lindley K. J., Verma A. K., Blauwet L. A. Peripartum cardiomyopathy: progress in understanding the etiology, management, and prognosis // Heart failure clinics. – 2019. – V. 15. – №. 1. – P. 29-39.doi: 10.1016/j.hfc.2018.08.004.
59. Dennis AT, Castro J, Carr C, Simmons S, Permezel M, Royse C. Haemodynamics in women with untreated pre-eclampsia. Anaesthesia 2012;67:1105–18.
60. Ntusi N. B. A. et al. Pregnancy-associated heart failure: a comparison of clinical presentation and outcome between hypertensive heart failure of pregnancy and idiopathic peripartum cardiomyopathy // PloS one. – 2015. – V. 10. – №. 8. – P. e0133466. doi: 10.1371/journal.pone.0133466
61. Van Spaendonck-Zwarts K. Y. et al. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy // Circulation. – 2010. – V. 121. – №. 20. – P. 2169-2175
62. Van Spaendonck-Zwarts K. Y. et al. Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy // European heart journal. – 2014. – V. 35. – №. 32. – P. 2165-2173
63. Ware J. S. et al. Shared genetic predisposition in peripartum and dilated cardiomyopathies // New England Journal of Medicine. – 2016. – V. 374. – №. 3. – С. 233-241.]
64. Sliwa K. et al. Long‐term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy // European journal of heart failure. – 2018. – V. 20. – №. 6. – P. 951-962. doi:10.1002/ejhf.1178
65. Azibani F., Sliwa K. Peripartum cardiomyopathy: an update // Current Heart Failure Reports. – 2018. – V. 15. – №. 5. – P. 297-306.